Experiment 478833
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | FORASTIERE,AA:. (1993). USE OF PACLITAXEL (TAXOL) IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK.. 20(4) |
| Amount utilized | |
| Compound isolated | |
| Disease | ONE PHASE II TRIAL OF PACLITAXEL IN HEAD AND NECK CANCER PATIENTS IS IN PROGRESS. THE PRELIMINARY RESULTS INDICATE PACLITAXEL HAS ACTIVITY AGAINST THIS TUMOR: TWO COMPLETE AND SEVEN PARTIAL RESPONSES IN 19 PATIENTS. |
| Dose amount | 250.0 MG |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |